Publication bias overstates effectiveness of SRIs for autism

04/23/2012 | Huffington Post, The

A review of 10 randomized, double-blind, controlled trials on the effectiveness of serotonin reuptake inhibitors for treating repetitive behaviors in autism showed a publication bias overstating the drug's benefits. Published trials found that the drug yielded small improvements in patients with autism, but after taking into account unpublished trials, the improvement lost its significance, researchers reported in the journal Pediatrics.

View Full Article in:

Huffington Post, The

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Learning Assessment Specialist at India's Leading K12 Education Enterprise
XSEED Education (India)
Gurgaon (New Delhi Area)
RFP Specialist, Contract Position
ASCD
Alexandria, VA
DIRECTOR OF LANGUAGE DEVELOPMENT
BOULDER VALLEY SCHOOL DISTRICT
Boulder, CO
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
DIRECTOR OF HEALTH AND CULTURE
BOULDER VALLEY SCHOOL DISTRICT
Boulder, CO